No Data
Hong Kong stock movement | Joinn Laboratories (06127) rose over 7% in the final hours as the potential of AI in pharmaceuticals is released, likely empowering the company's non-clinical research on drugs.
Joinn Laboratories (06127) surged over 7% in the late trading session, up 6.7% as of the time of writing, trading at 14.98 Hong Kong dollars, with a transaction amount of 33.8677 million Hong Kong dollars.
GTJA: AI technology drives efficiency innovation and optimizes the entire R&D chain of the CXO industry.
The penetration of AI technology accelerates the paradigm shift in the CXO industry. The deep application of AI technology in the Biomedical field is expected to reconstruct the value chain of the CXO industry.
Joinn Laboratories (06127.HK): As of February 28, a total of 3.2698 million A-shares have been repurchased.
On March 3, Gelonghui reported that Joinn Laboratories (06127.HK) announced that as of February 28, 2025, the company has cumulatively repurchased 3.2698 million A-shares through centralized bidding, accounting for 0.4363% of the total shares as of the announcement date. The maximum repurchase price was 18.15 yuan per share, the minimum repurchase price was 13.20 yuan per share, and the total amount of funds used was 52.992 million yuan (excluding transaction fees).
Trending Industry Today: WUXI BIO Leads Losses In CRO Stocks
Joinn Laboratories(China)Co.,Ltd. (SHSE:603127) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected
Trending Stocks Today: MINTH GROUP Surges 28.86%
Earnings Working Against Joinn Laboratories(China)Co.,Ltd.'s (SHSE:603127) Share Price
